The global burden of disease (GBD) was measured using a new indicator called disability-adjusted life years (DALYs). The formula to calculate DALYs is based on the idea of time being a continuous variable, which is not consistent with the way economic and health data are collected and reported,...

This study investigated inequalities in physically healthy days in the United States during 1993-1999, by socioeconomic and demographic group. The generalized entropy GE(2) and other indices were computed using data from the Behavioral Risk Factor Surveillance System survey, 1993-1999. The...

The availability of patient-level data from clinical trials has spurred a lot of interest in developing methods for quantifying and presenting uncertainty in cost-effectiveness analysis (CEA). Although the majority has focused on developing methods for using sample data to estimate a confidence...

We consider assumptions about preferences implicit in the person trade-off exercises used to derive health-related quality of life measures for the Global and US Burden of Disease Projects. Because these methods and their results have the potential of being adopted by other researchers, a...

Widespread use of antibiotics is considered the major driving force behind the development of antibiotic resistance. The benefits of exceeding the welfare-maximizing level of antibiotic use are below the costs of resistance created by this excess quantity of antibiotics used, thereby resulting...

We argue that health programs are administered in settings that often violate the frequently stated assumption of constant returns to scale in the provision of health services. Three types of returns to scale are identified from the general economic literature: returns to scale with respect to...